Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
Like many tumor types, pancreatic ductal adenocarcinoma (PDAC) exhibits a rich network of tumor-derived cytokines and chemokines that drive recruitment of myeloid cells to the tumor microenvironment (TME). These cells, which include tumor-associated macrophages and myeloid derived suppressor cells,...
Main Authors: | Robert H. Vonderheide, Adham S. Bear |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.605619/full |
Similar Items
-
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
by: Anita Thyagarajan, et al.
Published: (2019-10-01) -
Discovery of chemerin as the new chemoattractant of human mesenchymal stem cells
by: Irene Kim, et al.
Published: (2021-07-01) -
Mechanistic Studies in the Inflammatory Response of Pancreatitis and Pancreatric Cancer - Role of Myeloid Derived Suppressor Cells
by: Cieza Rubio, Napoleon Eduardo
Published: (2015) -
Chemotherapy and tumor microenvironment of pancreatic cancer
by: Qiaofei Liu, et al.
Published: (2017-07-01) -
The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion
by: Anthony eEvans, et al.
Published: (2012-07-01)